Bio

Adam Bellack is an industry-focused transactional lawyer in Goodwin’s Life Sciences group. He handles joint ventures, licenses, collaborations and other strategic, commercial and intellectual property transactions for clients engaged in all aspects of the healthcare industry. Adam’s clients range from startups and early stage pharma, biotech and medical device companies, to established Big Pharma companies and global manufacturers. Adam has also represented founders, venture funds, universities, hospitals, health systems and tech companies entering the healthcare space. Adam has worked on large transformative transactions and transactions involving cutting-edge technologies at the forefront of medical innovation, including novel immunotherapies, antibody-drug conjugates, drug delivery systems and gene therapies. His experience representing industry participants on “all sides” of these transactions provides unique perspective and helps him identify practical solutions to difficult problems when structuring and negotiating complex arrangements for life sciences companies.